Pandemic threat-level market indicators

[gsgs]

Re: Pandemic threat-level market indicators

Acambis up again to 132 now after the promising news
about the universal flu vaccine.

http://finance.yahoo.com/q/bc?s=ACM.L&t=5d&l=on&z=m&q=l&c=

 

[gsgs]

Re: Pandemic threat-level market indicators

positive reports in the German press.
Optimistic statements by Klenk and Pulz.
Watson says, the vaccine could come to market
in 3 years, in theory.

But the share is on the way down after reaching 136 as a top.

 

[doe22]

Re: Pandemic threat-level market indicators

nasdaq had a bad day but some of the bioflu stocks were up?

 

[Binkerbear]

Re: Pandemic threat-level market indicators

Down day on Wall St. but BCRX was up over 6% and NVAX up over 5%. Could this be the news out of Hong Kong ?

 

[Malcolm]

Re: Pandemic threat-level market indicators

http://www.earthtimes.org/articles/...-of-more-credit-losses-send-asian-stocks.html

Falling dollar, fears of more credit losses send Asian stocks down
Posted : Thu, 13 Mar 2008 10:28:05 GMT
Author : DPA
Category : Business

Tokyo - Asian stocks plummeted Thursday on worries about the dollar's weakness, rising credit-related losses and record oil prices. The biggest losses were seen in India, whose losses were exceeding 5 per cent ahead of the markets' close, and in Hong Kong, where the Hang Seng Index fell 4.79 per cent to 22,301.64 as a flu outbreak that prompted the closure of primary schools and kindergartens added to investor pessimism.

Stocks in Tokyo hit their lowest levels since August 2005 as the dollar fell below 100 yen for the first time in more than 12 years, hitting export-oriented shares.

Toyota Motor Corp, nearly 60 per cent of whose sales come from abroad, was among the day's big decliners because a stronger yen lowers the value of Japanese firms' overseas revenues.

The Nikkei 225 Stock Average tumbled 3.33 per cent to close at 12,433.44 while the broader Topix index of all first-section issues declined 3.13 per cent to 1,215.87.

A reason for the dollar's fall was the announcement by a Carlyle Group fund that it was unable to reach an agreement to reschedule its overdue debt and it expected lenders to "promptly" seize more than 16.6 billion dollars of its assets, which would send it into insolvency. The news caused speculation to rise that there would be more such announcements in the future and continuing credit-market losses would send the economy in the United States, Asia's biggest export market, into recession.

Analysts said a further contribution to the declines was Wall Street's losses overnight after US-based banks said the Federal Reserve's injection of another 200 billion dollars into the financial system might not free up credit.

"It doesn't fix the US' economic woes by creating new jobs and generating income for households to spend," agreed Kevin Scully, managing director of NetResearch Asia in Singapore.

Banks and exporters were among the biggest decliners around the region Thursday.

Other Asian markets seeing big losses were Singapore's Straits Times Index with a 3.85-per-cent plunge to 2,805.55, Taiwan's Taiex index with a 2.66-per-cent decline to 8,210.99 and South Korea's Kospi at a 2.6-per-cent fall to 1,615.62.

Australia's ASX 200 Index fell 2.32 per cent to 5,135.9 on expectations of a 13th-straight interest rate increase after unemployment there fell to a 33-year low of 4 per cent in February.

In mainland China, investors continued to worry about possible interest rate hikes and government measures to control record inflation, sending the Shanghai Composite Index down 2.43 per cent to 3,971.26 and the Shenzhen Composite Index down 3.3 per cent to 1,248.19.

Declines in India were led by banks and oil-refining issues. The Bombay Stock Exchange's 30-share Sensitive Index was off 5.36 per cent at 15,263.94, and the broader 50-share Nifty index of the National Stock Exchange was down 5.73 per cent to 4,592.65.

South-East Asian indices also declined, the Jakarta Composite Index by 4.52 per cent, the Kuala Lumpur Composite Index by 2.53 per cent and the Stock Exchange of Thailand Index by 1.53 per cent.

 

[Binkerbear]

Re: Pandemic threat-level market indicators

I just happened to notice that NVAX, BCRX, and AVII were all up to some extent today when most stocks tanked. Now I guess I'll have to go read thru all that complicated scientific stuff to see if anything is going on. :magnify:

Later ...maybe it's the Toronto rumor / news ? If these stocks open sharply higher on tomorrow's open, I'm guessing that the rumor is true. Gsgs: What does your analysis say ?

 

[Laidback Al]

Re: Pandemic threat-level market indicators

If these stocks open sharply higher on tomorrow's open, I'm guessing that the rumor is true.

No, . . . if they open higher tomorrow it only means that the market believes the rumors to be true.

 

[Binkerbear]

Re: Pandemic threat-level market indicators

A month ago I would have argued with that (the market is always right) but, after that guy Lewis sank a fortune into Bear-Stearns, I'll concede the point.

Otherwise, looks like there's no immediate pandemic on the horizon as these stocks all opened lower.

 

[gsgs]

Re: Pandemic threat-level market indicators

n=33                          030312 070415 070602  070905  071006  071228  082201 080320
-----------------------------------------------------------------------------------------
ACM.L Acambis                 250.00 140.00 130.00  125.00  130.00  120.00  120.00  119.50
AEMD.OB Aethlon Medical         0.50   0.60   0.65    0.68    0.59    0.72    0.57    0.48
ALNY  Alnylam Pharmaceutical    5.00  19.45  15.91   25.93   34.01   28.96   30.52   24.02
AMAR.OB Amarillo Biosciences    0.20   0.80   0.65    0.41    0.38    0.26    0.31    0.30
AVAN Avant Immunotherapy        1.00   1.42   0.95    0.63    0.51    0.47    0.59    7.25*
AVII AVI Biopharma Inc.         3.00   3.10   3.07    2.60    2.65    1.31    1.37    1.36
BCRX Biocryst Pharm. Inc.       1.50   9.91   8.27   12.54    7.36    5.89    5.63    3.30
BDSI Bio Delivery               2.00   6.00   5.13    3.94    3.86    2.80    2.54    2.34
BPAX BioSante Pharmaceuticals   2.20   6.50   6.80    6.05    5.61    3.85    3.57    2.16
BTA.AX  Biota                   0.50   1.58   1.72    1.71    1.62    1.20    0.90    1.29
CARN.PK Carrington Labs In      1.30   1.95   1.64    0.63    0.44    0.11    0.34*   0.42
CBIA.PK Canopus Biopharma Inc.  4.25*  4.25*  4.25*   4.25*   4.25*   7.00    8.00    3.10
CBMXD Acacia Res-Combimt        2.50   0.52   0.68    5.22*   5.76    7.40    8.49    9.48
CPHD Cepheid Inc                3.50  12.19  11.92   19.33   24.58   26.43   30.31   22.36
CRXL Crucell NV ADS             2.50  25.89  22.90   20.25   19.90   16.64   14.79   13.40
CSL.AX  CSL                    13.00  85.00  88.80  100.35  103.86   36.29*  32.10   37.88
EFSF.OB efoodsafety             0.40   0.38   0.37    0.30    0.24    0.21    0.21    0.18
ENCO CVGR Covalent Group        2.30   3.80   3.10    2.81    2.90    1.63    2.07    1.99
GILD Gilead Sciences           18.00  78.42  83.00   36.47*2 41.86   46.33   46.17   47.81
GNBT Generex Biotech            1.00   1.66   1.40    1.53    1.49    1.66    1.42    0.85
GNVC GenVec                     1.50   4.10   3.21    2.29    2.42    1.37    1.61    1.50
HEB  Hemispherx Biopharm        1.50   1.74   1.52    1.20    1.64    0.82    0.66    0.75
IVGN Invitrogen                30.00  67.00  73.50   79.66   83.80   92.41   94.60   79.73
MEDI Medimmune Inc             30.00  44.19  57.96   58.00*  58.00*  58.00*  17.64*  17.40
NNVC.OB Nanoviricides           1.20*  1.20   1.10    0.60    0.70    0.40    0.37    0.54
NSTK Nastech Pharm              7.00  12.26  12.17   14.15   15.24    3.97    3.05    2.52
NVAX Novavax Inc                3.00   3.02   3.14    3.41    3.87    3.35    2.88    2.53
OMRI Omrix Biopharmaceuticals  10.00  37.50  34.50   33.91   37.70   34.53   27.43   12.13
PDGI SFCC SFBC                  7.00  28.00  32.50   28.16   31.53   40.82   42.13   25.81
PDH.F Acambis                   3.00   2.00   1.90    1.78    1.71    1.49    1.69    1.51
QDEL Quidel CP                  2.50  12.61  14.57   16.81   19.81   19.53   17.07   15.69
QIA.DE                                13.00  12.50   12.50   13.70   15.00   13.01   11.98
SVA  Sinovac Biotech            1.00   3.39   2.80    3.60    5.66    5.20    3.95    3.15
TYA.F Toyama chemical           5.30   4.80   4.60    4.18    4.05    4.22    4.21    5.55
VICL Vical Inc.                 2.30   5.25   5.07    5.10    4.81    4.20    4.07    3.47
VXGN.PK Vaxgen Inc              2.50   2.00   1.65    1.43    1.45    0.57    0.60    0.43
------------------------------------------------------------------------------------------
                                       2.786  0.961   0.988   1.030   0.819   0.981   0.920

CHIR
PSC Protein sciences
Medimmune --> AstraZeneca for $15.6B = $58 per share


bfi4.bas
http://finance.yahoo.com/p?k=pf_2

 

[Binkerbear]

Re: Pandemic threat-level market indicators

Today saw AVII up almost 5 %, NVAX up 5 %, and BCRX up 14 % - all of this with no company specific news. Gold and oil fell around the same time that two of these made most of their sharp moves up. As usual, it's probably nothing unless there's continued follow-thru.

 

[Binkerbear]

Re: Pandemic threat-level market indicators

These stocks that I watch have started out the gate strong with oil and gold dropping on signs of a world-wide recession ending the commodities boom. OTOH, there aren't even any 'scary' rumors out there about imminent PF.

 

[gsgs]

Re: Pandemic threat-level market indicators

can you watch the other BF-stocks too ?

you could probably easily create a virtual portfolio at finance.yahoo.com
and just copy these symbols :

ACM.L AEMD.OB ALNY AMAR.OB AVAND AVII BCRX BDSI BPAX BTA.AX CARN.OB CBIA.PK CBMX CPHD CRXL CSL.AX EFSF.OB ENCO GILD GNBT GNVC HEB IOMI IVGN LMNX NNVC.OB NSTK NVAX OMRI PDGI PDH.F QDEL QIA.DE SVA TYA.F VICL VXGN.OB

(additions ?)

works maybe for other financial services too, I don't know.




Symbol Last Trade Change Volume Related Info
- - - - - ACM.L 9:39AM ET 125.00 3.00 2.46% 61,984 Chart, Profile, more...
- - - - - AEMD.OB Mar 31 0.53 0.00 0.00% 0 Chart, Message, Profile, more...
- - - - - ALNY 9:55AM ET 24.11 0.29 1.19% 211,286 Chart, Message, Profile, more...
- - - - - AMAR.OB Mar 31 0.31 0.00 0.00% 0 Chart, Message, Profile, more...
- - - - - AVAND 9:49AM ET 10.09 0.29 2.96% 8,331 Chart, Message, Profile, more...
- - - - - AVII 9:54AM ET 1.86 0.02 1.09% 45,299 Chart, Message, Profile, more...
- - - - - BCRX 9:55AM ET 4.90 0.29 6.29% 19,991 Chart, Message, Profile, more...
- - - - - BDSI 9:31AM ET 2.35 0.02 0.86% 900 Chart, Message, Profile, more...
- - - - - BPAX 9:54AM ET 4.35 0.21 4.60% 51,886 Chart, Message, Profile, more...
- - - - - BTA.AX 1:11AM ET 1.18 0.03 2.48% 572,651 Chart, more...
- - - - - CARN.OB Mar 31 0.54 0.00 0.00% 0 Chart, Message, Profile, more...
- - - - - CBIA.PK Mar 27 8.75 0.00 0.00% 0 Chart, Message, more...
- - - - - CBMX 9:49AM ET 9.74 0.06 0.63% 4,578 Chart, Message, Profile, more...
- - - - - CPHD 9:55AM ET 24.28 0.11 0.45% 82,563 Chart, Message, Profile, more...
- - - - - CRXL 9:53AM ET 15.31 0.10 0.65% 140,697 Chart, Message, Profile, more...
- - - - - CSL.AX 1:11AM ET 36.56 0.35 0.95% 1,012,111 Chart, more...
- - - - - EFSF.OB 9:54AM ET 0.17 0.0000 0.00% 26,000 Chart, Message, Profile, more...
- - - - - ENCO 3:32PM ET 1.95 0.00 0.00% 0 Chart, Message, Profile, more...
- - - - - GILD 9:55AM ET 52.33 0.80 1.55% 1,072,544 Chart, Message, Profile, more...
- - - - - GNBT 9:55AM ET 1.03 0.07 6.50% 221,043 Chart, Message, Profile, more...
- - - - - GNVC 9:48AM ET 1.78 0.02 1.14% 23,325 Chart, Message, Profile, more...
- - - - - HEB 9:43AM ET 0.73 0.00 0.00% 400 Chart, Message, Profile, more...
- - - - - IOMI 9:30AM ET 1.60 0.00 0.00% 100 Chart, Message, Profile, more...
- - - - - IVGN 9:55AM ET 86.45 0.98 1.15% 62,965 Chart, Message, Profile, more...
- - - - - LMNX 9:54AM ET 19.77 0.12 0.61% 20,760 Chart, Message, Profile, more...
- - - - - NNVC.OB 9:30AM ET 0.54 0.00 0.00% 100 Chart, Message, Profile, more...
- - - - - NSTK 9:55AM ET 2.57 0.22 9.36% 36,399 Chart, Message, Profile, more...
- - - - - NVAX 9:49AM ET 2.67 0.01 0.38% 10,320 Chart, Message, Profile, more...
- - - - - OMRI 9:55AM ET 14.25 0.25 1.79% 25,439 Chart, Message, Profile, more...
- - - - - PDGI 9:55AM ET 25.71 0.48 1.90% 11,580 Chart, Message, Profile, more...
- - - - - PDH.F 3:29AM ET 1.50 0.09 6.38% 9,000 Chart, more...
- - - - - QDEL 9:54AM ET 16.66 0.60 3.74% 38,354 Chart, Message, Profile, more...
- - - - - QIA.DE 9:55AM ET 13.42 0.32 2.44% 453,432 Chart, more...
- - - - - SVA 9:48AM ET 3.63 0.01 0.27% 5,600 Chart, Message, Profile, more...
- - - - - TYA.F 3:04AM ET 5.49 0.01 0.18% 1,000 Chart, more...
- - - - - VICL 9:49AM ET 3.52 0.00 0.00% 2,250 Chart, Message, Profile, more...
- - - - - VXGN.OB 9:48AM ET 0.48 0.0050 1.06% 314 Chart, Message, Profile, more...


+0.86% in average (n=37)

 

[Binkerbear]

Re: Pandemic threat-level market indicators

gsgs, I could but I've spent my life trying to backtest stock systems with no avail. If the volume picks up, you'll see some of these on the CNBC ticker. Then I'd check the forums. Specifically, if I turn on CNBC tomorrow AM, an see NVAX showing up (and trading up) in pre-market, then I'll go to the internet and check other stocks and rumors. This has only happened back during those Turkish clusters a few years ago.

 

[Binkerbear]

Re: Pandemic threat-level market indicators

BioCryst Pharmaceuticals shares jump as injectible flu therapy meets midstage study goal

BIRMINGHAM, Ala. (AP) -- Shares of drug developer BioCryst Pharmaceuticals Inc. jumped Monday after the company said an injectible version of its experimental seasonal flu drug met a midstage study goal of alleviating symptoms.
<TABLE cellSpacing=4 cellPadding=4 align=left border=0><TBODY><TR><TD><TABLE class=ad_slug_table cellSpacing=0 cellPadding=0 border=0><TBODY><TR><TD align=middle>[SIZE=-2]ADVERTISEMENT[/SIZE]
</TD></TR></TBODY></TABLE><SCRIPT language=javascript>if(window.yzq_d==null)window.yzq_d=new Object();window.yzq_d['mLzVD9G_fyc-']='&U=13fm2iqgi%2fN%3dmLzVD9G_fyc-%2fC%3d626899.12331415.12723508.1383221%2fD%3dLREC%2fB%3d5133107%2fV%3d1';</SCRIPT><NOSCRIPT></NOSCRIPT></TD></TR></TBODY></TABLE>The drug, called peramivir, was given to patients in a single-dose injection, within 48 hours of showing symptoms and compared with placebo. Based on the preliminary results from the 300-person study, BioCryst said it is preparing for a late-stage clinical trial.
The company's stock surged 53 cents, or 20 percent, to $3.15. Shares have traded between $2.55 and $13.18 over the past 52 weeks.
The next phase of development will also focus on an injectible version for treatment outside of a hospital setting. The company is also conducting a midstage study on an version that can be injected directly into a muscle.
The study was conducted by BioCryst's partner, Japan-based Shionogi & Co. The companies started collaborating in Febuary of 2007, and BioCryst retains rights to peramivir in North America, Europe, and other countries outside of Japan and Korea.

 

[gsgs]

Re: Pandemic threat-level market indicators

Symbol Last Trade Change Volume Related Info
- - - - - ACM.L 9:54AM ET 187.25 0.25 0.13% 6,325 Chart, Profile, more...
- - - - - AEMD.OB 11:00AM ET 0.44 0.00 1.15% 5,500 Chart, Message, Profile, more...
- - - - - ALNY 11:02AM ET 34.85 0.39 1.13% 139,822 Chart, Message, Profile, more...
- - - - - AMAR.OB 9:45AM ET 0.22 0.01 4.35% 15,000 Chart, Message, Profile, more...
- - - - - AVAN 11:00AM ET 15.78 0.39 2.53% 40,508 Chart, Message, Profile, more...
- - - - - AVII 10:57AM ET 1.23 0.01 0.82% 18,906 Chart, Message, Profile, more...
- - - - - BCRX 10:59AM ET 3.15 0.00 0.10% 19,641 Chart, Message, Profile, more...
- - - - - BDSI 10:33AM ET 2.05 0.02 1.03% 2,565 Chart, Message, Profile, more...
- - - - - BPAX 11:02AM ET 5.21 0.00 0.00% 4,201 Chart, Message, Profile, more...
- - - - - BTA.AX 2:10AM ET 0.72 0.03 3.60% 168,036 Chart, more...
'CARN.OB' is no longer valid. It has changed to DSII.OB
- - - - - CBIA.PK Aug 13 4.00 0.00 0.00% 0 Chart, Message, more...
- - - - - CBMX 10:57AM ET 12.75 0.17 1.35% 8,910 Chart, Message, Profile, more...
- - - - - CPHD 11:02AM ET 20.28 0.08 0.39% 370,505 Chart, Message, Profile, more...
- - - - - CRXL 10:59AM ET 17.45 0.18 1.04% 3,837 Chart, Message, more...
- - - - - CSL.AX 2:10AM ET 37.00 0.65 1.73% 7,707,439 Chart, more...
- - - - - EFSF.OB Aug 14 0.08 0.0000 0.00% 0 Chart, Message, Profile, more...
- - - - - ENCO Aug 14 1.86 0.00 0.00% 0 Chart, Message, Profile, more...
- - - - - GILD 11:02AM ET 56.20 0.49 0.86% 2,330,828 Chart, Message, Profile, more...
- - - - - GNBT 11:01AM ET 0.71 0.0010 0.14% 91,843 Chart, Message, Profile, more...
- - - - - GNVC 11:00AM ET 1.52 0.04 2.70% 75,909 Chart, Message, Profile, more...
- - - - - HEB 10:14AM ET 0.73 0.00 0.07% 100 Chart, Message, Profile, more...
No such ticker symbol IOMI. Try Symbol Lookup
- - - - - IVGN 11:01AM ET 43.45 0.12 0.28% 308,039 Chart, Message, Profile, more...
- - - - - LMNX 11:02AM ET 24.99 0.39 1.54% 193,363 Chart, Message, Profile, more...
- - - - - NNVC.OB 10:55AM ET 1.30 0.00 0.00% 3,300 Chart, Message, Profile, more...
- - - - - NSTK Jun 9 1.19 0.00 0.00% 0 Chart, more...
- - - - - NVAX 11:00AM ET 2.89 0.01 0.34% 81,001 Chart, Message, Profile, more...
- - - - - OMRI 11:01AM ET 22.16 0.34 1.56% 104,664 Chart, Message, Profile, more...
- - - - - PDGI 11:01AM ET 26.74 0.26 0.96% 74,632 Chart, Message, Profile, more...
- - - - - PDH.F 3:34AM ET 2.30 0.00 0.00% 1,724 Chart, more...
- - - - - QDEL 11:01AM ET 19.97 0.27 1.37% 75,888 Chart, Message, Profile, more...
- - - - - QIA.DE 11:01AM ET 14.49 0.68 4.92% 1,510,964 Chart, more...
- - - - - SVA 11:00AM ET 3.38 0.12 3.46% 30,089 Chart, Message, Profile, more...
- - - - - TYA.F Aug 8 5.21 0.09 1.76% 4,000 Chart, more...
- - - - - VICL 10:30AM ET 3.35 0.0199 0.59% 800 Chart, Message, Profile, more...
- - - - - VXGN.OB Aug 14 0.70 0.00 0.00% 0 Chart, Message, Profile, more...

 

[Laidback Al]

Re: Pandemic threat-level market indicators

Comparing the data posted by gsgs in April and August with the percent change.

<TABLE style="WIDTH: 446pt; BORDER-COLLAPSE: collapse" cellSpacing=0 cellPadding=0 width=592 border=0 x:str><COLGROUP><COL style="WIDTH: 65pt; mso-width-source: userset; mso-width-alt: 3145" width=86><COL style="WIDTH: 76pt; mso-width-source: userset; mso-width-alt: 3693" width=101><COL style="WIDTH: 106pt; mso-width-source: userset; mso-width-alt: 5156" width=141><COL style="WIDTH: 92pt; mso-width-source: userset; mso-width-alt: 4461" width=122><COL style="WIDTH: 107pt; mso-width-source: userset; mso-width-alt: 5193" width=142><TBODY><TR style="HEIGHT: 12.75pt" height=17><TD style="BORDER-RIGHT: #d4d0c8; BORDER-TOP: #d4d0c8; BORDER-LEFT: #d4d0c8; WIDTH: 65pt; BORDER-BOTTOM: #d4d0c8; HEIGHT: 12.75pt; BACKGROUND-COLOR: transparent" width=86 height=17>Symbol</TD><TD class=xl25 style="BORDER-RIGHT: #d4d0c8; BORDER-TOP: #d4d0c8; BORDER-LEFT: #d4d0c8; WIDTH: 76pt; BORDER-BOTTOM: #d4d0c8; BACKGROUND-COLOR: transparent" width=101>Price April 1</TD><TD class=xl25 style="BORDER-RIGHT: #d4d0c8; BORDER-TOP: #d4d0c8; BORDER-LEFT: #d4d0c8; WIDTH: 106pt; BORDER-BOTTOM: #d4d0c8; BACKGROUND-COLOR: transparent" width=141>____ Price August 15</TD><TD class=xl25 style="BORDER-RIGHT: #d4d0c8; BORDER-TOP: #d4d0c8; BORDER-LEFT: #d4d0c8; WIDTH: 92pt; BORDER-BOTTOM: #d4d0c8; BACKGROUND-COLOR: transparent" width=122 x:str="____ Change ">____ Change </TD><TD class=xl25 style="BORDER-RIGHT: #d4d0c8; BORDER-TOP: #d4d0c8; BORDER-LEFT: #d4d0c8; WIDTH: 107pt; BORDER-BOTTOM: #d4d0c8; BACKGROUND-COLOR: transparent" width=142>_____ Percent Change</TD></TR><TR style="HEIGHT: 12.75pt" height=17><TD style="BORDER-RIGHT: #d4d0c8; BORDER-TOP: #d4d0c8; BORDER-LEFT: #d4d0c8; BORDER-BOTTOM: #d4d0c8; HEIGHT: 12.75pt; BACKGROUND-COLOR: transparent" height=17>ACM.L</TD><TD style="BORDER-RIGHT: #d4d0c8; BORDER-TOP: #d4d0c8; BORDER-LEFT: #d4d0c8; BORDER-BOTTOM: #d4d0c8; BACKGROUND-COLOR: transparent" align=right x:num>125</TD><TD style="BORDER-RIGHT: #d4d0c8; BORDER-TOP: #d4d0c8; BORDER-LEFT: #d4d0c8; BORDER-BOTTOM: #d4d0c8; BACKGROUND-COLOR: transparent" align=right x:num>187.25</TD><TD style="BORDER-RIGHT: #d4d0c8; BORDER-TOP: #d4d0c8; BORDER-LEFT: #d4d0c8; BORDER-BOTTOM: #d4d0c8; BACKGROUND-COLOR: transparent" align=right x:num x:fmla="=C2-B2">62.25</TD><TD class=xl24 style="BORDER-RIGHT: #d4d0c8; BORDER-TOP: #d4d0c8; BORDER-LEFT: #d4d0c8; BORDER-BOTTOM: #d4d0c8; BACKGROUND-COLOR: transparent" align=right x:num="0.498" x:fmla="=D2/B2">49.80%</TD></TR><TR style="HEIGHT: 12.75pt" height=17><TD style="BORDER-RIGHT: #d4d0c8; BORDER-TOP: #d4d0c8; BORDER-LEFT: #d4d0c8; BORDER-BOTTOM: #d4d0c8; HEIGHT: 12.75pt; BACKGROUND-COLOR: transparent" height=17>AEMD.OB</TD><TD style="BORDER-RIGHT: #d4d0c8; BORDER-TOP: #d4d0c8; BORDER-LEFT: #d4d0c8; BORDER-BOTTOM: #d4d0c8; BACKGROUND-COLOR: transparent" align=right x:num>0.53</TD><TD style="BORDER-RIGHT: #d4d0c8; BORDER-TOP: #d4d0c8; BORDER-LEFT: #d4d0c8; BORDER-BOTTOM: #d4d0c8; BACKGROUND-COLOR: transparent" align=right x:num>0.44</TD><TD style="BORDER-RIGHT: #d4d0c8; BORDER-TOP: #d4d0c8; BORDER-LEFT: #d4d0c8; BORDER-BOTTOM: #d4d0c8; BACKGROUND-COLOR: transparent" align=right x:num x:fmla="=C3-B3">-0.09</TD><TD class=xl24 style="BORDER-RIGHT: #d4d0c8; BORDER-TOP: #d4d0c8; BORDER-LEFT: #d4d0c8; BORDER-BOTTOM: #d4d0c8; BACKGROUND-COLOR: transparent" align=right x:num="-0.16981132075471703" x:fmla="=D3/B3">-16.98%</TD></TR><TR style="HEIGHT: 12.75pt" height=17><TD style="BORDER-RIGHT: #d4d0c8; BORDER-TOP: #d4d0c8; BORDER-LEFT: #d4d0c8; BORDER-BOTTOM: #d4d0c8; HEIGHT: 12.75pt; BACKGROUND-COLOR: transparent" height=17>ALNY</TD><TD style="BORDER-RIGHT: #d4d0c8; BORDER-TOP: #d4d0c8; BORDER-LEFT: #d4d0c8; BORDER-BOTTOM: #d4d0c8; BACKGROUND-COLOR: transparent" align=right x:num>24.11</TD><TD style="BORDER-RIGHT: #d4d0c8; BORDER-TOP: #d4d0c8; BORDER-LEFT: #d4d0c8; BORDER-BOTTOM: #d4d0c8; BACKGROUND-COLOR: transparent" align=right x:num>34.85</TD><TD style="BORDER-RIGHT: #d4d0c8; BORDER-TOP: #d4d0c8; BORDER-LEFT: #d4d0c8; BORDER-BOTTOM: #d4d0c8; BACKGROUND-COLOR: transparent" align=right x:num x:fmla="=C4-B4">10.74</TD><TD class=xl24 style="BORDER-RIGHT: #d4d0c8; BORDER-TOP: #d4d0c8; BORDER-LEFT: #d4d0c8; BORDER-BOTTOM: #d4d0c8; BACKGROUND-COLOR: transparent" align=right x:num="0.44545831605143105" x:fmla="=D4/B4">44.55%</TD></TR><TR style="HEIGHT: 12.75pt" height=17><TD style="BORDER-RIGHT: #d4d0c8; BORDER-TOP: #d4d0c8; BORDER-LEFT: #d4d0c8; BORDER-BOTTOM: #d4d0c8; HEIGHT: 12.75pt; BACKGROUND-COLOR: transparent" height=17>AMAR.OB</TD><TD style="BORDER-RIGHT: #d4d0c8; BORDER-TOP: #d4d0c8; BORDER-LEFT: #d4d0c8; BORDER-BOTTOM: #d4d0c8; BACKGROUND-COLOR: transparent" align=right x:num>0.31</TD><TD style="BORDER-RIGHT: #d4d0c8; BORDER-TOP: #d4d0c8; BORDER-LEFT: #d4d0c8; BORDER-BOTTOM: #d4d0c8; BACKGROUND-COLOR: transparent" align=right x:num>0.22</TD><TD style="BORDER-RIGHT: #d4d0c8; BORDER-TOP: #d4d0c8; BORDER-LEFT: #d4d0c8; BORDER-BOTTOM: #d4d0c8; BACKGROUND-COLOR: transparent" align=right x:num x:fmla="=C5-B5">-0.09</TD><TD class=xl24 style="BORDER-RIGHT: #d4d0c8; BORDER-TOP: #d4d0c8; BORDER-LEFT: #d4d0c8; BORDER-BOTTOM: #d4d0c8; BACKGROUND-COLOR: transparent" align=right x:num="-0.29032258064516125" x:fmla="=D5/B5">-29.03%</TD></TR><TR style="HEIGHT: 12.75pt" height=17><TD style="BORDER-RIGHT: #d4d0c8; BORDER-TOP: #d4d0c8; BORDER-LEFT: #d4d0c8; BORDER-BOTTOM: #d4d0c8; HEIGHT: 12.75pt; BACKGROUND-COLOR: transparent" height=17>AVAN</TD><TD style="BORDER-RIGHT: #d4d0c8; BORDER-TOP: #d4d0c8; BORDER-LEFT: #d4d0c8; BORDER-BOTTOM: #d4d0c8; BACKGROUND-COLOR: transparent" align=right x:num>10.09</TD><TD style="BORDER-RIGHT: #d4d0c8; BORDER-TOP: #d4d0c8; BORDER-LEFT: #d4d0c8; BORDER-BOTTOM: #d4d0c8; BACKGROUND-COLOR: transparent" align=right x:num>15.78</TD><TD style="BORDER-RIGHT: #d4d0c8; BORDER-TOP: #d4d0c8; BORDER-LEFT: #d4d0c8; BORDER-BOTTOM: #d4d0c8; BACKGROUND-COLOR: transparent" align=right x:num x:fmla="=C6-B6">5.69</TD><TD class=xl24 style="BORDER-RIGHT: #d4d0c8; BORDER-TOP: #d4d0c8; BORDER-LEFT: #d4d0c8; BORDER-BOTTOM: #d4d0c8; BACKGROUND-COLOR: transparent" align=right x:num="0.56392467789890977" x:fmla="=D6/B6">56.39%</TD></TR><TR style="HEIGHT: 12.75pt" height=17><TD style="BORDER-RIGHT: #d4d0c8; BORDER-TOP: #d4d0c8; BORDER-LEFT: #d4d0c8; BORDER-BOTTOM: #d4d0c8; HEIGHT: 12.75pt; BACKGROUND-COLOR: transparent" height=17>AVII</TD><TD style="BORDER-RIGHT: #d4d0c8; BORDER-TOP: #d4d0c8; BORDER-LEFT: #d4d0c8; BORDER-BOTTOM: #d4d0c8; BACKGROUND-COLOR: transparent" align=right x:num>1.86</TD><TD style="BORDER-RIGHT: #d4d0c8; BORDER-TOP: #d4d0c8; BORDER-LEFT: #d4d0c8; BORDER-BOTTOM: #d4d0c8; BACKGROUND-COLOR: transparent" align=right x:num>1.23</TD><TD style="BORDER-RIGHT: #d4d0c8; BORDER-TOP: #d4d0c8; BORDER-LEFT: #d4d0c8; BORDER-BOTTOM: #d4d0c8; BACKGROUND-COLOR: transparent" align=right x:num x:fmla="=C7-B7">-0.63</TD><TD class=xl24 style="BORDER-RIGHT: #d4d0c8; BORDER-TOP: #d4d0c8; BORDER-LEFT: #d4d0c8; BORDER-BOTTOM: #d4d0c8; BACKGROUND-COLOR: transparent" align=right x:num="-0.33870967741935487" x:fmla="=D7/B7">-33.87%</TD></TR><TR style="HEIGHT: 12.75pt" height=17><TD style="BORDER-RIGHT: #d4d0c8; BORDER-TOP: #d4d0c8; BORDER-LEFT: #d4d0c8; BORDER-BOTTOM: #d4d0c8; HEIGHT: 12.75pt; BACKGROUND-COLOR: transparent" height=17>BCRX</TD><TD style="BORDER-RIGHT: #d4d0c8; BORDER-TOP: #d4d0c8; BORDER-LEFT: #d4d0c8; BORDER-BOTTOM: #d4d0c8; BACKGROUND-COLOR: transparent" align=right x:num>4.9</TD><TD style="BORDER-RIGHT: #d4d0c8; BORDER-TOP: #d4d0c8; BORDER-LEFT: #d4d0c8; BORDER-BOTTOM: #d4d0c8; BACKGROUND-COLOR: transparent" align=right x:num>3.15</TD><TD style="BORDER-RIGHT: #d4d0c8; BORDER-TOP: #d4d0c8; BORDER-LEFT: #d4d0c8; BORDER-BOTTOM: #d4d0c8; BACKGROUND-COLOR: transparent" align=right x:num x:fmla="=C8-B8">-1.75</TD><TD class=xl24 style="BORDER-RIGHT: #d4d0c8; BORDER-TOP: #d4d0c8; BORDER-LEFT: #d4d0c8; BORDER-BOTTOM: #d4d0c8; BACKGROUND-COLOR: transparent" align=right x:num="-0.35714285714285721" x:fmla="=D8/B8">-35.71%</TD></TR><TR style="HEIGHT: 12.75pt" height=17><TD style="BORDER-RIGHT: #d4d0c8; BORDER-TOP: #d4d0c8; BORDER-LEFT: #d4d0c8; BORDER-BOTTOM: #d4d0c8; HEIGHT: 12.75pt; BACKGROUND-COLOR: transparent" height=17>BDSI</TD><TD style="BORDER-RIGHT: #d4d0c8; BORDER-TOP: #d4d0c8; BORDER-LEFT: #d4d0c8; BORDER-BOTTOM: #d4d0c8; BACKGROUND-COLOR: transparent" align=right x:num>2.35</TD><TD style="BORDER-RIGHT: #d4d0c8; BORDER-TOP: #d4d0c8; BORDER-LEFT: #d4d0c8; BORDER-BOTTOM: #d4d0c8; BACKGROUND-COLOR: transparent" align=right x:num>2.05</TD><TD style="BORDER-RIGHT: #d4d0c8; BORDER-TOP: #d4d0c8; BORDER-LEFT: #d4d0c8; BORDER-BOTTOM: #d4d0c8; BACKGROUND-COLOR: transparent" align=right x:num x:fmla="=C9-B9">-0.3</TD><TD class=xl24 style="BORDER-RIGHT: #d4d0c8; BORDER-TOP: #d4d0c8; BORDER-LEFT: #d4d0c8; BORDER-BOTTOM: #d4d0c8; BACKGROUND-COLOR: transparent" align=right x:num="-0.12765957446808521" x:fmla="=D9/B9">-12.77%</TD></TR><TR style="HEIGHT: 12.75pt" height=17><TD style="BORDER-RIGHT: #d4d0c8; BORDER-TOP: #d4d0c8; BORDER-LEFT: #d4d0c8; BORDER-BOTTOM: #d4d0c8; HEIGHT: 12.75pt; BACKGROUND-COLOR: transparent" height=17>BPAX</TD><TD style="BORDER-RIGHT: #d4d0c8; BORDER-TOP: #d4d0c8; BORDER-LEFT: #d4d0c8; BORDER-BOTTOM: #d4d0c8; BACKGROUND-COLOR: transparent" align=right x:num>4.35</TD><TD style="BORDER-RIGHT: #d4d0c8; BORDER-TOP: #d4d0c8; BORDER-LEFT: #d4d0c8; BORDER-BOTTOM: #d4d0c8; BACKGROUND-COLOR: transparent" align=right x:num>5.21</TD><TD style="BORDER-RIGHT: #d4d0c8; BORDER-TOP: #d4d0c8; BORDER-LEFT: #d4d0c8; BORDER-BOTTOM: #d4d0c8; BACKGROUND-COLOR: transparent" align=right x:num x:fmla="=C10-B10">0.86</TD><TD class=xl24 style="BORDER-RIGHT: #d4d0c8; BORDER-TOP: #d4d0c8; BORDER-LEFT: #d4d0c8; BORDER-BOTTOM: #d4d0c8; BACKGROUND-COLOR: transparent" align=right x:num="0.19770114942528744" x:fmla="=D10/B10">19.77%</TD></TR><TR style="HEIGHT: 12.75pt" height=17><TD style="BORDER-RIGHT: #d4d0c8; BORDER-TOP: #d4d0c8; BORDER-LEFT: #d4d0c8; BORDER-BOTTOM: #d4d0c8; HEIGHT: 12.75pt; BACKGROUND-COLOR: transparent" height=17>BTA.AX</TD><TD style="BORDER-RIGHT: #d4d0c8; BORDER-TOP: #d4d0c8; BORDER-LEFT: #d4d0c8; BORDER-BOTTOM: #d4d0c8; BACKGROUND-COLOR: transparent" align=right x:num>1.18</TD><TD style="BORDER-RIGHT: #d4d0c8; BORDER-TOP: #d4d0c8; BORDER-LEFT: #d4d0c8; BORDER-BOTTOM: #d4d0c8; BACKGROUND-COLOR: transparent" align=right x:num>0.72</TD><TD style="BORDER-RIGHT: #d4d0c8; BORDER-TOP: #d4d0c8; BORDER-LEFT: #d4d0c8; BORDER-BOTTOM: #d4d0c8; BACKGROUND-COLOR: transparent" align=right x:num x:fmla="=C11-B11">-0.46</TD><TD class=xl24 style="BORDER-RIGHT: #d4d0c8; BORDER-TOP: #d4d0c8; BORDER-LEFT: #d4d0c8; BORDER-BOTTOM: #d4d0c8; BACKGROUND-COLOR: transparent" align=right x:num="-0.38983050847457629" x:fmla="=D11/B11">-38.98%</TD></TR><TR style="HEIGHT: 12.75pt" height=17><TD style="BORDER-RIGHT: #d4d0c8; BORDER-TOP: #d4d0c8; BORDER-LEFT: #d4d0c8; BORDER-BOTTOM: #d4d0c8; HEIGHT: 12.75pt; BACKGROUND-COLOR: transparent" height=17>CARN.OB</TD><TD style="BORDER-RIGHT: #d4d0c8; BORDER-TOP: #d4d0c8; BORDER-LEFT: #d4d0c8; BORDER-BOTTOM: #d4d0c8; BACKGROUND-COLOR: transparent"></TD><TD style="BORDER-RIGHT: #d4d0c8; BORDER-TOP: #d4d0c8; BORDER-LEFT: #d4d0c8; BORDER-BOTTOM: #d4d0c8; BACKGROUND-COLOR: transparent"></TD><TD style="BORDER-RIGHT: #d4d0c8; BORDER-TOP: #d4d0c8; BORDER-LEFT: #d4d0c8; BORDER-BOTTOM: #d4d0c8; BACKGROUND-COLOR: transparent"></TD><TD class=xl24 style="BORDER-RIGHT: #d4d0c8; BORDER-TOP: #d4d0c8; BORDER-LEFT: #d4d0c8; BORDER-BOTTOM: #d4d0c8; BACKGROUND-COLOR: transparent"></TD></TR><TR style="HEIGHT: 12.75pt" height=17><TD style="BORDER-RIGHT: #d4d0c8; BORDER-TOP: #d4d0c8; BORDER-LEFT: #d4d0c8; BORDER-BOTTOM: #d4d0c8; HEIGHT: 12.75pt; BACKGROUND-COLOR: transparent" height=17>CBIA.PK</TD><TD style="BORDER-RIGHT: #d4d0c8; BORDER-TOP: #d4d0c8; BORDER-LEFT: #d4d0c8; BORDER-BOTTOM: #d4d0c8; BACKGROUND-COLOR: transparent" align=right x:num>8.75</TD><TD style="BORDER-RIGHT: #d4d0c8; BORDER-TOP: #d4d0c8; BORDER-LEFT: #d4d0c8; BORDER-BOTTOM: #d4d0c8; BACKGROUND-COLOR: transparent" align=right x:num>4</TD><TD style="BORDER-RIGHT: #d4d0c8; BORDER-TOP: #d4d0c8; BORDER-LEFT: #d4d0c8; BORDER-BOTTOM: #d4d0c8; BACKGROUND-COLOR: transparent" align=right x:num x:fmla="=C13-B13">-4.75</TD><TD class=xl24 style="BORDER-RIGHT: #d4d0c8; BORDER-TOP: #d4d0c8; BORDER-LEFT: #d4d0c8; BORDER-BOTTOM: #d4d0c8; BACKGROUND-COLOR: transparent" align=right x:num="-0.54285714285714282" x:fmla="=D13/B13">-54.29%</TD></TR><TR style="HEIGHT: 12.75pt" height=17><TD style="BORDER-RIGHT: #d4d0c8; BORDER-TOP: #d4d0c8; BORDER-LEFT: #d4d0c8; BORDER-BOTTOM: #d4d0c8; HEIGHT: 12.75pt; BACKGROUND-COLOR: transparent" height=17>CBMX</TD><TD style="BORDER-RIGHT: #d4d0c8; BORDER-TOP: #d4d0c8; BORDER-LEFT: #d4d0c8; BORDER-BOTTOM: #d4d0c8; BACKGROUND-COLOR: transparent" align=right x:num>9.74</TD><TD style="BORDER-RIGHT: #d4d0c8; BORDER-TOP: #d4d0c8; BORDER-LEFT: #d4d0c8; BORDER-BOTTOM: #d4d0c8; BACKGROUND-COLOR: transparent" align=right x:num>12.75</TD><TD style="BORDER-RIGHT: #d4d0c8; BORDER-TOP: #d4d0c8; BORDER-LEFT: #d4d0c8; BORDER-BOTTOM: #d4d0c8; BACKGROUND-COLOR: transparent" align=right x:num x:fmla="=C14-B14">3.01</TD><TD class=xl24 style="BORDER-RIGHT: #d4d0c8; BORDER-TOP: #d4d0c8; BORDER-LEFT: #d4d0c8; BORDER-BOTTOM: #d4d0c8; BACKGROUND-COLOR: transparent" align=right x:num="0.30903490759753588" x:fmla="=D14/B14">30.90%</TD></TR><TR style="HEIGHT: 12.75pt" height=17><TD style="BORDER-RIGHT: #d4d0c8; BORDER-TOP: #d4d0c8; BORDER-LEFT: #d4d0c8; BORDER-BOTTOM: #d4d0c8; HEIGHT: 12.75pt; BACKGROUND-COLOR: transparent" height=17>CPHD</TD><TD style="BORDER-RIGHT: #d4d0c8; BORDER-TOP: #d4d0c8; BORDER-LEFT: #d4d0c8; BORDER-BOTTOM: #d4d0c8; BACKGROUND-COLOR: transparent" align=right x:num>24.28</TD><TD style="BORDER-RIGHT: #d4d0c8; BORDER-TOP: #d4d0c8; BORDER-LEFT: #d4d0c8; BORDER-BOTTOM: #d4d0c8; BACKGROUND-COLOR: transparent" align=right x:num>20.28</TD><TD style="BORDER-RIGHT: #d4d0c8; BORDER-TOP: #d4d0c8; BORDER-LEFT: #d4d0c8; BORDER-BOTTOM: #d4d0c8; BACKGROUND-COLOR: transparent" align=right x:num x:fmla="=C15-B15">-4</TD><TD class=xl24 style="BORDER-RIGHT: #d4d0c8; BORDER-TOP: #d4d0c8; BORDER-LEFT: #d4d0c8; BORDER-BOTTOM: #d4d0c8; BACKGROUND-COLOR: transparent" align=right x:num="-0.16474464579901152" x:fmla="=D15/B15">-16.47%</TD></TR><TR style="HEIGHT: 12.75pt" height=17><TD style="BORDER-RIGHT: #d4d0c8; BORDER-TOP: #d4d0c8; BORDER-LEFT: #d4d0c8; BORDER-BOTTOM: #d4d0c8; HEIGHT: 12.75pt; BACKGROUND-COLOR: transparent" height=17>CRXL</TD><TD style="BORDER-RIGHT: #d4d0c8; BORDER-TOP: #d4d0c8; BORDER-LEFT: #d4d0c8; BORDER-BOTTOM: #d4d0c8; BACKGROUND-COLOR: transparent" align=right x:num>15.31</TD><TD style="BORDER-RIGHT: #d4d0c8; BORDER-TOP: #d4d0c8; BORDER-LEFT: #d4d0c8; BORDER-BOTTOM: #d4d0c8; BACKGROUND-COLOR: transparent" align=right x:num>17.45</TD><TD style="BORDER-RIGHT: #d4d0c8; BORDER-TOP: #d4d0c8; BORDER-LEFT: #d4d0c8; BORDER-BOTTOM: #d4d0c8; BACKGROUND-COLOR: transparent" align=right x:num x:fmla="=C16-B16">2.14</TD><TD class=xl24 style="BORDER-RIGHT: #d4d0c8; BORDER-TOP: #d4d0c8; BORDER-LEFT: #d4d0c8; BORDER-BOTTOM: #d4d0c8; BACKGROUND-COLOR: transparent" align=right x:num="0.13977792292619196" x:fmla="=D16/B16">13.98%</TD></TR><TR style="HEIGHT: 12.75pt" height=17><TD style="BORDER-RIGHT: #d4d0c8; BORDER-TOP: #d4d0c8; BORDER-LEFT: #d4d0c8; BORDER-BOTTOM: #d4d0c8; HEIGHT: 12.75pt; BACKGROUND-COLOR: transparent" height=17>CSL.AX</TD><TD style="BORDER-RIGHT: #d4d0c8; BORDER-TOP: #d4d0c8; BORDER-LEFT: #d4d0c8; BORDER-BOTTOM: #d4d0c8; BACKGROUND-COLOR: transparent" align=right x:num>36.56</TD><TD style="BORDER-RIGHT: #d4d0c8; BORDER-TOP: #d4d0c8; BORDER-LEFT: #d4d0c8; BORDER-BOTTOM: #d4d0c8; BACKGROUND-COLOR: transparent" align=right x:num>37</TD><TD style="BORDER-RIGHT: #d4d0c8; BORDER-TOP: #d4d0c8; BORDER-LEFT: #d4d0c8; BORDER-BOTTOM: #d4d0c8; BACKGROUND-COLOR: transparent" align=right x:num="0.43999999999999773" x:fmla="=C17-B17">0.44</TD><TD class=xl24 style="BORDER-RIGHT: #d4d0c8; BORDER-TOP: #d4d0c8; BORDER-LEFT: #d4d0c8; BORDER-BOTTOM: #d4d0c8; BACKGROUND-COLOR: transparent" align=right x:num="1.2035010940918973E-2" x:fmla="=D17/B17">1.20%</TD></TR><TR style="HEIGHT: 12.75pt" height=17><TD style="BORDER-RIGHT: #d4d0c8; BORDER-TOP: #d4d0c8; BORDER-LEFT: #d4d0c8; BORDER-BOTTOM: #d4d0c8; HEIGHT: 12.75pt; BACKGROUND-COLOR: transparent" height=17>EFSF.OB</TD><TD style="BORDER-RIGHT: #d4d0c8; BORDER-TOP: #d4d0c8; BORDER-LEFT: #d4d0c8; BORDER-BOTTOM: #d4d0c8; BACKGROUND-COLOR: transparent" align=right x:num>0.17</TD><TD style="BORDER-RIGHT: #d4d0c8; BORDER-TOP: #d4d0c8; BORDER-LEFT: #d4d0c8; BORDER-BOTTOM: #d4d0c8; BACKGROUND-COLOR: transparent" align=right x:num>0.08</TD><TD style="BORDER-RIGHT: #d4d0c8; BORDER-TOP: #d4d0c8; BORDER-LEFT: #d4d0c8; BORDER-BOTTOM: #d4d0c8; BACKGROUND-COLOR: transparent" align=right x:num x:fmla="=C18-B18">-0.09</TD><TD class=xl24 style="BORDER-RIGHT: #d4d0c8; BORDER-TOP: #d4d0c8; BORDER-LEFT: #d4d0c8; BORDER-BOTTOM: #d4d0c8; BACKGROUND-COLOR: transparent" align=right x:num="-0.52941176470588236" x:fmla="=D18/B18">-52.94%</TD></TR><TR style="HEIGHT: 12.75pt" height=17><TD style="BORDER-RIGHT: #d4d0c8; BORDER-TOP: #d4d0c8; BORDER-LEFT: #d4d0c8; BORDER-BOTTOM: #d4d0c8; HEIGHT: 12.75pt; BACKGROUND-COLOR: transparent" height=17>ENCO</TD><TD style="BORDER-RIGHT: #d4d0c8; BORDER-TOP: #d4d0c8; BORDER-LEFT: #d4d0c8; BORDER-BOTTOM: #d4d0c8; BACKGROUND-COLOR: transparent" align=right x:num>1.95</TD><TD style="BORDER-RIGHT: #d4d0c8; BORDER-TOP: #d4d0c8; BORDER-LEFT: #d4d0c8; BORDER-BOTTOM: #d4d0c8; BACKGROUND-COLOR: transparent" align=right x:num>1.86</TD><TD style="BORDER-RIGHT: #d4d0c8; BORDER-TOP: #d4d0c8; BORDER-LEFT: #d4d0c8; BORDER-BOTTOM: #d4d0c8; BACKGROUND-COLOR: transparent" align=right x:num="-8.9999999999999858E-2" x:fmla="=C19-B19">-0.09</TD><TD class=xl24 style="BORDER-RIGHT: #d4d0c8; BORDER-TOP: #d4d0c8; BORDER-LEFT: #d4d0c8; BORDER-BOTTOM: #d4d0c8; BACKGROUND-COLOR: transparent" align=right x:num="-4.615384615384608E-2" x:fmla="=D19/B19">-4.62%</TD></TR><TR style="HEIGHT: 12.75pt" height=17><TD style="BORDER-RIGHT: #d4d0c8; BORDER-TOP: #d4d0c8; BORDER-LEFT: #d4d0c8; BORDER-BOTTOM: #d4d0c8; HEIGHT: 12.75pt; BACKGROUND-COLOR: transparent" height=17>GILD</TD><TD style="BORDER-RIGHT: #d4d0c8; BORDER-TOP: #d4d0c8; BORDER-LEFT: #d4d0c8; BORDER-BOTTOM: #d4d0c8; BACKGROUND-COLOR: transparent" align=right x:num>52.33</TD><TD style="BORDER-RIGHT: #d4d0c8; BORDER-TOP: #d4d0c8; BORDER-LEFT: #d4d0c8; BORDER-BOTTOM: #d4d0c8; BACKGROUND-COLOR: transparent" align=right x:num>56.2</TD><TD style="BORDER-RIGHT: #d4d0c8; BORDER-TOP: #d4d0c8; BORDER-LEFT: #d4d0c8; BORDER-BOTTOM: #d4d0c8; BACKGROUND-COLOR: transparent" align=right x:num x:fmla="=C20-B20">3.87</TD><TD class=xl24 style="BORDER-RIGHT: #d4d0c8; BORDER-TOP: #d4d0c8; BORDER-LEFT: #d4d0c8; BORDER-BOTTOM: #d4d0c8; BACKGROUND-COLOR: transparent" align=right x:num="7.3953755016243156E-2" x:fmla="=D20/B20">7.40%</TD></TR><TR style="HEIGHT: 12.75pt" height=17><TD style="BORDER-RIGHT: #d4d0c8; BORDER-TOP: #d4d0c8; BORDER-LEFT: #d4d0c8; BORDER-BOTTOM: #d4d0c8; HEIGHT: 12.75pt; BACKGROUND-COLOR: transparent" height=17>GNBT</TD><TD style="BORDER-RIGHT: #d4d0c8; BORDER-TOP: #d4d0c8; BORDER-LEFT: #d4d0c8; BORDER-BOTTOM: #d4d0c8; BACKGROUND-COLOR: transparent" align=right x:num>1.03</TD><TD style="BORDER-RIGHT: #d4d0c8; BORDER-TOP: #d4d0c8; BORDER-LEFT: #d4d0c8; BORDER-BOTTOM: #d4d0c8; BACKGROUND-COLOR: transparent" align=right x:num>0.71</TD><TD style="BORDER-RIGHT: #d4d0c8; BORDER-TOP: #d4d0c8; BORDER-LEFT: #d4d0c8; BORDER-BOTTOM: #d4d0c8; BACKGROUND-COLOR: transparent" align=right x:num x:fmla="=C21-B21">-0.32</TD><TD class=xl24 style="BORDER-RIGHT: #d4d0c8; BORDER-TOP: #d4d0c8; BORDER-LEFT: #d4d0c8; BORDER-BOTTOM: #d4d0c8; BACKGROUND-COLOR: transparent" align=right x:num="-0.31067961165048547" x:fmla="=D21/B21">-31.07%</TD></TR><TR style="HEIGHT: 12.75pt" height=17><TD style="BORDER-RIGHT: #d4d0c8; BORDER-TOP: #d4d0c8; BORDER-LEFT: #d4d0c8; BORDER-BOTTOM: #d4d0c8; HEIGHT: 12.75pt; BACKGROUND-COLOR: transparent" height=17>GNVC</TD><TD style="BORDER-RIGHT: #d4d0c8; BORDER-TOP: #d4d0c8; BORDER-LEFT: #d4d0c8; BORDER-BOTTOM: #d4d0c8; BACKGROUND-COLOR: transparent" align=right x:num>1.78</TD><TD style="BORDER-RIGHT: #d4d0c8; BORDER-TOP: #d4d0c8; BORDER-LEFT: #d4d0c8; BORDER-BOTTOM: #d4d0c8; BACKGROUND-COLOR: transparent" align=right x:num>1.52</TD><TD style="BORDER-RIGHT: #d4d0c8; BORDER-TOP: #d4d0c8; BORDER-LEFT: #d4d0c8; BORDER-BOTTOM: #d4d0c8; BACKGROUND-COLOR: transparent" align=right x:num x:fmla="=C22-B22">-0.26</TD><TD class=xl24 style="BORDER-RIGHT: #d4d0c8; BORDER-TOP: #d4d0c8; BORDER-LEFT: #d4d0c8; BORDER-BOTTOM: #d4d0c8; BACKGROUND-COLOR: transparent" align=right x:num="-0.14606741573033707" x:fmla="=D22/B22">-14.61%</TD></TR><TR style="HEIGHT: 12.75pt" height=17><TD style="BORDER-RIGHT: #d4d0c8; BORDER-TOP: #d4d0c8; BORDER-LEFT: #d4d0c8; BORDER-BOTTOM: #d4d0c8; HEIGHT: 12.75pt; BACKGROUND-COLOR: transparent" height=17>HEB</TD><TD style="BORDER-RIGHT: #d4d0c8; BORDER-TOP: #d4d0c8; BORDER-LEFT: #d4d0c8; BORDER-BOTTOM: #d4d0c8; BACKGROUND-COLOR: transparent" align=right x:num>0.73</TD><TD style="BORDER-RIGHT: #d4d0c8; BORDER-TOP: #d4d0c8; BORDER-LEFT: #d4d0c8; BORDER-BOTTOM: #d4d0c8; BACKGROUND-COLOR: transparent" align=right x:num>0.73</TD><TD style="BORDER-RIGHT: #d4d0c8; BORDER-TOP: #d4d0c8; BORDER-LEFT: #d4d0c8; BORDER-BOTTOM: #d4d0c8; BACKGROUND-COLOR: transparent" align=right x:num x:fmla="=C23-B23">0</TD><TD class=xl24 style="BORDER-RIGHT: #d4d0c8; BORDER-TOP: #d4d0c8; BORDER-LEFT: #d4d0c8; BORDER-BOTTOM: #d4d0c8; BACKGROUND-COLOR: transparent" align=right x:num="0" x:fmla="=D23/B23">0.00%</TD></TR><TR style="HEIGHT: 12.75pt" height=17><TD style="BORDER-RIGHT: #d4d0c8; BORDER-TOP: #d4d0c8; BORDER-LEFT: #d4d0c8; BORDER-BOTTOM: #d4d0c8; HEIGHT: 12.75pt; BACKGROUND-COLOR: transparent" height=17>IOMI</TD><TD style="BORDER-RIGHT: #d4d0c8; BORDER-TOP: #d4d0c8; BORDER-LEFT: #d4d0c8; BORDER-BOTTOM: #d4d0c8; BACKGROUND-COLOR: transparent"></TD><TD style="BORDER-RIGHT: #d4d0c8; BORDER-TOP: #d4d0c8; BORDER-LEFT: #d4d0c8; BORDER-BOTTOM: #d4d0c8; BACKGROUND-COLOR: transparent"></TD><TD style="BORDER-RIGHT: #d4d0c8; BORDER-TOP: #d4d0c8; BORDER-LEFT: #d4d0c8; BORDER-BOTTOM: #d4d0c8; BACKGROUND-COLOR: transparent"></TD><TD class=xl24 style="BORDER-RIGHT: #d4d0c8; BORDER-TOP: #d4d0c8; BORDER-LEFT: #d4d0c8; BORDER-BOTTOM: #d4d0c8; BACKGROUND-COLOR: transparent"></TD></TR><TR style="HEIGHT: 12.75pt" height=17><TD style="BORDER-RIGHT: #d4d0c8; BORDER-TOP: #d4d0c8; BORDER-LEFT: #d4d0c8; BORDER-BOTTOM: #d4d0c8; HEIGHT: 12.75pt; BACKGROUND-COLOR: transparent" height=17>IVGN</TD><TD style="BORDER-RIGHT: #d4d0c8; BORDER-TOP: #d4d0c8; BORDER-LEFT: #d4d0c8; BORDER-BOTTOM: #d4d0c8; BACKGROUND-COLOR: transparent" align=right x:num>86.45</TD><TD style="BORDER-RIGHT: #d4d0c8; BORDER-TOP: #d4d0c8; BORDER-LEFT: #d4d0c8; BORDER-BOTTOM: #d4d0c8; BACKGROUND-COLOR: transparent" align=right x:num>43.45</TD><TD style="BORDER-RIGHT: #d4d0c8; BORDER-TOP: #d4d0c8; BORDER-LEFT: #d4d0c8; BORDER-BOTTOM: #d4d0c8; BACKGROUND-COLOR: transparent" align=right x:num x:fmla="=C25-B25">-43</TD><TD class=xl24 style="BORDER-RIGHT: #d4d0c8; BORDER-TOP: #d4d0c8; BORDER-LEFT: #d4d0c8; BORDER-BOTTOM: #d4d0c8; BACKGROUND-COLOR: transparent" align=right x:num="-0.49739733950260262" x:fmla="=D25/B25">-49.74%</TD></TR><TR style="HEIGHT: 12.75pt" height=17><TD style="BORDER-RIGHT: #d4d0c8; BORDER-TOP: #d4d0c8; BORDER-LEFT: #d4d0c8; BORDER-BOTTOM: #d4d0c8; HEIGHT: 12.75pt; BACKGROUND-COLOR: transparent" height=17>LMNX</TD><TD style="BORDER-RIGHT: #d4d0c8; BORDER-TOP: #d4d0c8; BORDER-LEFT: #d4d0c8; BORDER-BOTTOM: #d4d0c8; BACKGROUND-COLOR: transparent" align=right x:num>19.77</TD><TD style="BORDER-RIGHT: #d4d0c8; BORDER-TOP: #d4d0c8; BORDER-LEFT: #d4d0c8; BORDER-BOTTOM: #d4d0c8; BACKGROUND-COLOR: transparent" align=right x:num>24.99</TD><TD style="BORDER-RIGHT: #d4d0c8; BORDER-TOP: #d4d0c8; BORDER-LEFT: #d4d0c8; BORDER-BOTTOM: #d4d0c8; BACKGROUND-COLOR: transparent" align=right x:num x:fmla="=C26-B26">5.22</TD><TD class=xl24 style="BORDER-RIGHT: #d4d0c8; BORDER-TOP: #d4d0c8; BORDER-LEFT: #d4d0c8; BORDER-BOTTOM: #d4d0c8; BACKGROUND-COLOR: transparent" align=right x:num="0.2640364188163884" x:fmla="=D26/B26">26.40%</TD></TR><TR style="HEIGHT: 12.75pt" height=17><TD style="BORDER-RIGHT: #d4d0c8; BORDER-TOP: #d4d0c8; BORDER-LEFT: #d4d0c8; BORDER-BOTTOM: #d4d0c8; HEIGHT: 12.75pt; BACKGROUND-COLOR: transparent" height=17>NNVC.OB</TD><TD style="BORDER-RIGHT: #d4d0c8; BORDER-TOP: #d4d0c8; BORDER-LEFT: #d4d0c8; BORDER-BOTTOM: #d4d0c8; BACKGROUND-COLOR: transparent" align=right x:num>0.54</TD><TD style="BORDER-RIGHT: #d4d0c8; BORDER-TOP: #d4d0c8; BORDER-LEFT: #d4d0c8; BORDER-BOTTOM: #d4d0c8; BACKGROUND-COLOR: transparent" align=right x:num>1.3</TD><TD style="BORDER-RIGHT: #d4d0c8; BORDER-TOP: #d4d0c8; BORDER-LEFT: #d4d0c8; BORDER-BOTTOM: #d4d0c8; BACKGROUND-COLOR: transparent" align=right x:num x:fmla="=C27-B27">0.76</TD><TD class=xl24 style="BORDER-RIGHT: #d4d0c8; BORDER-TOP: #d4d0c8; BORDER-LEFT: #d4d0c8; BORDER-BOTTOM: #d4d0c8; BACKGROUND-COLOR: transparent" align=right x:num="1.4074074074074074" x:fmla="=D27/B27">140.74%</TD></TR><TR style="HEIGHT: 12.75pt" height=17><TD style="BORDER-RIGHT: #d4d0c8; BORDER-TOP: #d4d0c8; BORDER-LEFT: #d4d0c8; BORDER-BOTTOM: #d4d0c8; HEIGHT: 12.75pt; BACKGROUND-COLOR: transparent" height=17>NSTK</TD><TD style="BORDER-RIGHT: #d4d0c8; BORDER-TOP: #d4d0c8; BORDER-LEFT: #d4d0c8; BORDER-BOTTOM: #d4d0c8; BACKGROUND-COLOR: transparent" align=right x:num>2.57</TD><TD style="BORDER-RIGHT: #d4d0c8; BORDER-TOP: #d4d0c8; BORDER-LEFT: #d4d0c8; BORDER-BOTTOM: #d4d0c8; BACKGROUND-COLOR: transparent" align=right x:num>1.19</TD><TD style="BORDER-RIGHT: #d4d0c8; BORDER-TOP: #d4d0c8; BORDER-LEFT: #d4d0c8; BORDER-BOTTOM: #d4d0c8; BACKGROUND-COLOR: transparent" align=right x:num x:fmla="=C28-B28">-1.38</TD><TD class=xl24 style="BORDER-RIGHT: #d4d0c8; BORDER-TOP: #d4d0c8; BORDER-LEFT: #d4d0c8; BORDER-BOTTOM: #d4d0c8; BACKGROUND-COLOR: transparent" align=right x:num="-0.53696498054474706" x:fmla="=D28/B28">-53.70%</TD></TR><TR style="HEIGHT: 12.75pt" height=17><TD style="BORDER-RIGHT: #d4d0c8; BORDER-TOP: #d4d0c8; BORDER-LEFT: #d4d0c8; BORDER-BOTTOM: #d4d0c8; HEIGHT: 12.75pt; BACKGROUND-COLOR: transparent" height=17>NVAX</TD><TD style="BORDER-RIGHT: #d4d0c8; BORDER-TOP: #d4d0c8; BORDER-LEFT: #d4d0c8; BORDER-BOTTOM: #d4d0c8; BACKGROUND-COLOR: transparent" align=right x:num>2.67</TD><TD style="BORDER-RIGHT: #d4d0c8; BORDER-TOP: #d4d0c8; BORDER-LEFT: #d4d0c8; BORDER-BOTTOM: #d4d0c8; BACKGROUND-COLOR: transparent" align=right x:num>2.89</TD><TD style="BORDER-RIGHT: #d4d0c8; BORDER-TOP: #d4d0c8; BORDER-LEFT: #d4d0c8; BORDER-BOTTOM: #d4d0c8; BACKGROUND-COLOR: transparent" align=right x:num x:fmla="=C29-B29">0.22</TD><TD class=xl24 style="BORDER-RIGHT: #d4d0c8; BORDER-TOP: #d4d0c8; BORDER-LEFT: #d4d0c8; BORDER-BOTTOM: #d4d0c8; BACKGROUND-COLOR: transparent" align=right x:num="8.2397003745318428E-2" x:fmla="=D29/B29">8.24%</TD></TR><TR style="HEIGHT: 12.75pt" height=17><TD style="BORDER-RIGHT: #d4d0c8; BORDER-TOP: #d4d0c8; BORDER-LEFT: #d4d0c8; BORDER-BOTTOM: #d4d0c8; HEIGHT: 12.75pt; BACKGROUND-COLOR: transparent" height=17>OMRI</TD><TD style="BORDER-RIGHT: #d4d0c8; BORDER-TOP: #d4d0c8; BORDER-LEFT: #d4d0c8; BORDER-BOTTOM: #d4d0c8; BACKGROUND-COLOR: transparent" align=right x:num>14.25</TD><TD style="BORDER-RIGHT: #d4d0c8; BORDER-TOP: #d4d0c8; BORDER-LEFT: #d4d0c8; BORDER-BOTTOM: #d4d0c8; BACKGROUND-COLOR: transparent" align=right x:num>22.16</TD><TD style="BORDER-RIGHT: #d4d0c8; BORDER-TOP: #d4d0c8; BORDER-LEFT: #d4d0c8; BORDER-BOTTOM: #d4d0c8; BACKGROUND-COLOR: transparent" align=right x:num x:fmla="=C30-B30">7.91</TD><TD class=xl24 style="BORDER-RIGHT: #d4d0c8; BORDER-TOP: #d4d0c8; BORDER-LEFT: #d4d0c8; BORDER-BOTTOM: #d4d0c8; BACKGROUND-COLOR: transparent" align=right x:num="0.55508771929824563" x:fmla="=D30/B30">55.51%</TD></TR><TR style="HEIGHT: 12.75pt" height=17><TD style="BORDER-RIGHT: #d4d0c8; BORDER-TOP: #d4d0c8; BORDER-LEFT: #d4d0c8; BORDER-BOTTOM: #d4d0c8; HEIGHT: 12.75pt; BACKGROUND-COLOR: transparent" height=17>PDGI</TD><TD style="BORDER-RIGHT: #d4d0c8; BORDER-TOP: #d4d0c8; BORDER-LEFT: #d4d0c8; BORDER-BOTTOM: #d4d0c8; BACKGROUND-COLOR: transparent" align=right x:num>25.71</TD><TD style="BORDER-RIGHT: #d4d0c8; BORDER-TOP: #d4d0c8; BORDER-LEFT: #d4d0c8; BORDER-BOTTOM: #d4d0c8; BACKGROUND-COLOR: transparent" align=right x:num>26.74</TD><TD style="BORDER-RIGHT: #d4d0c8; BORDER-TOP: #d4d0c8; BORDER-LEFT: #d4d0c8; BORDER-BOTTOM: #d4d0c8; BACKGROUND-COLOR: transparent" align=right x:num x:fmla="=C31-B31">1.03</TD><TD class=xl24 style="BORDER-RIGHT: #d4d0c8; BORDER-TOP: #d4d0c8; BORDER-LEFT: #d4d0c8; BORDER-BOTTOM: #d4d0c8; BACKGROUND-COLOR: transparent" align=right x:num="4.0062232594321179E-2" x:fmla="=D31/B31">4.01%</TD></TR><TR style="HEIGHT: 12.75pt" height=17><TD style="BORDER-RIGHT: #d4d0c8; BORDER-TOP: #d4d0c8; BORDER-LEFT: #d4d0c8; BORDER-BOTTOM: #d4d0c8; HEIGHT: 12.75pt; BACKGROUND-COLOR: transparent" height=17>PDH.F</TD><TD style="BORDER-RIGHT: #d4d0c8; BORDER-TOP: #d4d0c8; BORDER-LEFT: #d4d0c8; BORDER-BOTTOM: #d4d0c8; BACKGROUND-COLOR: transparent" align=right x:num>1.5</TD><TD style="BORDER-RIGHT: #d4d0c8; BORDER-TOP: #d4d0c8; BORDER-LEFT: #d4d0c8; BORDER-BOTTOM: #d4d0c8; BACKGROUND-COLOR: transparent" align=right x:num>2.3</TD><TD style="BORDER-RIGHT: #d4d0c8; BORDER-TOP: #d4d0c8; BORDER-LEFT: #d4d0c8; BORDER-BOTTOM: #d4d0c8; BACKGROUND-COLOR: transparent" align=right x:num x:fmla="=C32-B32">0.8</TD><TD class=xl24 style="BORDER-RIGHT: #d4d0c8; BORDER-TOP: #d4d0c8; BORDER-LEFT: #d4d0c8; BORDER-BOTTOM: #d4d0c8; BACKGROUND-COLOR: transparent" align=right x:num="0.53333333333333321" x:fmla="=D32/B32">53.33%</TD></TR><TR style="HEIGHT: 12.75pt" height=17><TD style="BORDER-RIGHT: #d4d0c8; BORDER-TOP: #d4d0c8; BORDER-LEFT: #d4d0c8; BORDER-BOTTOM: #d4d0c8; HEIGHT: 12.75pt; BACKGROUND-COLOR: transparent" height=17>QDEL</TD><TD style="BORDER-RIGHT: #d4d0c8; BORDER-TOP: #d4d0c8; BORDER-LEFT: #d4d0c8; BORDER-BOTTOM: #d4d0c8; BACKGROUND-COLOR: transparent" align=right x:num>16.66</TD><TD style="BORDER-RIGHT: #d4d0c8; BORDER-TOP: #d4d0c8; BORDER-LEFT: #d4d0c8; BORDER-BOTTOM: #d4d0c8; BACKGROUND-COLOR: transparent" align=right x:num>19.97</TD><TD style="BORDER-RIGHT: #d4d0c8; BORDER-TOP: #d4d0c8; BORDER-LEFT: #d4d0c8; BORDER-BOTTOM: #d4d0c8; BACKGROUND-COLOR: transparent" align=right x:num x:fmla="=C33-B33">3.31</TD><TD class=xl24 style="BORDER-RIGHT: #d4d0c8; BORDER-TOP: #d4d0c8; BORDER-LEFT: #d4d0c8; BORDER-BOTTOM: #d4d0c8; BACKGROUND-COLOR: transparent" align=right x:num="0.19867947178871539" x:fmla="=D33/B33">19.87%</TD></TR><TR style="HEIGHT: 12.75pt" height=17><TD style="BORDER-RIGHT: #d4d0c8; BORDER-TOP: #d4d0c8; BORDER-LEFT: #d4d0c8; BORDER-BOTTOM: #d4d0c8; HEIGHT: 12.75pt; BACKGROUND-COLOR: transparent" height=17>QIA.DE</TD><TD style="BORDER-RIGHT: #d4d0c8; BORDER-TOP: #d4d0c8; BORDER-LEFT: #d4d0c8; BORDER-BOTTOM: #d4d0c8; BACKGROUND-COLOR: transparent" align=right x:num>13.42</TD><TD style="BORDER-RIGHT: #d4d0c8; BORDER-TOP: #d4d0c8; BORDER-LEFT: #d4d0c8; BORDER-BOTTOM: #d4d0c8; BACKGROUND-COLOR: transparent" align=right x:num>14.49</TD><TD style="BORDER-RIGHT: #d4d0c8; BORDER-TOP: #d4d0c8; BORDER-LEFT: #d4d0c8; BORDER-BOTTOM: #d4d0c8; BACKGROUND-COLOR: transparent" align=right x:num x:fmla="=C34-B34">1.07</TD><TD class=xl24 style="BORDER-RIGHT: #d4d0c8; BORDER-TOP: #d4d0c8; BORDER-LEFT: #d4d0c8; BORDER-BOTTOM: #d4d0c8; BACKGROUND-COLOR: transparent" align=right x:num="7.9731743666169919E-2" x:fmla="=D34/B34">7.97%</TD></TR><TR style="HEIGHT: 12.75pt" height=17><TD style="BORDER-RIGHT: #d4d0c8; BORDER-TOP: #d4d0c8; BORDER-LEFT: #d4d0c8; BORDER-BOTTOM: #d4d0c8; HEIGHT: 12.75pt; BACKGROUND-COLOR: transparent" height=17>SVA</TD><TD style="BORDER-RIGHT: #d4d0c8; BORDER-TOP: #d4d0c8; BORDER-LEFT: #d4d0c8; BORDER-BOTTOM: #d4d0c8; BACKGROUND-COLOR: transparent" align=right x:num>3.63</TD><TD style="BORDER-RIGHT: #d4d0c8; BORDER-TOP: #d4d0c8; BORDER-LEFT: #d4d0c8; BORDER-BOTTOM: #d4d0c8; BACKGROUND-COLOR: transparent" align=right x:num>3.38</TD><TD style="BORDER-RIGHT: #d4d0c8; BORDER-TOP: #d4d0c8; BORDER-LEFT: #d4d0c8; BORDER-BOTTOM: #d4d0c8; BACKGROUND-COLOR: transparent" align=right x:num x:fmla="=C35-B35">-0.25</TD><TD class=xl24 style="BORDER-RIGHT: #d4d0c8; BORDER-TOP: #d4d0c8; BORDER-LEFT: #d4d0c8; BORDER-BOTTOM: #d4d0c8; BACKGROUND-COLOR: transparent" align=right x:num="-6.8870523415977963E-2" x:fmla="=D35/B35">-6.89%</TD></TR><TR style="HEIGHT: 12.75pt" height=17><TD style="BORDER-RIGHT: #d4d0c8; BORDER-TOP: #d4d0c8; BORDER-LEFT: #d4d0c8; BORDER-BOTTOM: #d4d0c8; HEIGHT: 12.75pt; BACKGROUND-COLOR: transparent" height=17>TYA.F</TD><TD style="BORDER-RIGHT: #d4d0c8; BORDER-TOP: #d4d0c8; BORDER-LEFT: #d4d0c8; BORDER-BOTTOM: #d4d0c8; BACKGROUND-COLOR: transparent" align=right x:num>5.49</TD><TD style="BORDER-RIGHT: #d4d0c8; BORDER-TOP: #d4d0c8; BORDER-LEFT: #d4d0c8; BORDER-BOTTOM: #d4d0c8; BACKGROUND-COLOR: transparent" align=right x:num>5.21</TD><TD style="BORDER-RIGHT: #d4d0c8; BORDER-TOP: #d4d0c8; BORDER-LEFT: #d4d0c8; BORDER-BOTTOM: #d4d0c8; BACKGROUND-COLOR: transparent" align=right x:num x:fmla="=C36-B36">-0.28</TD><TD class=xl24 style="BORDER-RIGHT: #d4d0c8; BORDER-TOP: #d4d0c8; BORDER-LEFT: #d4d0c8; BORDER-BOTTOM: #d4d0c8; BACKGROUND-COLOR: transparent" align=right x:num="-5.1001821493624817E-2" x:fmla="=D36/B36">-5.10%</TD></TR><TR style="HEIGHT: 12.75pt" height=17><TD style="BORDER-RIGHT: #d4d0c8; BORDER-TOP: #d4d0c8; BORDER-LEFT: #d4d0c8; BORDER-BOTTOM: #d4d0c8; HEIGHT: 12.75pt; BACKGROUND-COLOR: transparent" height=17>VICL</TD><TD style="BORDER-RIGHT: #d4d0c8; BORDER-TOP: #d4d0c8; BORDER-LEFT: #d4d0c8; BORDER-BOTTOM: #d4d0c8; BACKGROUND-COLOR: transparent" align=right x:num>3.52</TD><TD style="BORDER-RIGHT: #d4d0c8; BORDER-TOP: #d4d0c8; BORDER-LEFT: #d4d0c8; BORDER-BOTTOM: #d4d0c8; BACKGROUND-COLOR: transparent" align=right x:num>3.35</TD><TD style="BORDER-RIGHT: #d4d0c8; BORDER-TOP: #d4d0c8; BORDER-LEFT: #d4d0c8; BORDER-BOTTOM: #d4d0c8; BACKGROUND-COLOR: transparent" align=right x:num x:fmla="=C37-B37">-0.17</TD><TD class=xl24 style="BORDER-RIGHT: #d4d0c8; BORDER-TOP: #d4d0c8; BORDER-LEFT: #d4d0c8; BORDER-BOTTOM: #d4d0c8; BACKGROUND-COLOR: transparent" align=right x:num="-4.8295454545454523E-2" x:fmla="=D37/B37">-4.83%</TD></TR><TR style="HEIGHT: 12.75pt" height=17><TD style="BORDER-RIGHT: #d4d0c8; BORDER-TOP: #d4d0c8; BORDER-LEFT: #d4d0c8; BORDER-BOTTOM: #d4d0c8; HEIGHT: 12.75pt; BACKGROUND-COLOR: transparent" height=17>VXGN.OB</TD><TD style="BORDER-RIGHT: #d4d0c8; BORDER-TOP: #d4d0c8; BORDER-LEFT: #d4d0c8; BORDER-BOTTOM: #d4d0c8; BACKGROUND-COLOR: transparent" align=right x:num>0.48</TD><TD style="BORDER-RIGHT: #d4d0c8; BORDER-TOP: #d4d0c8; BORDER-LEFT: #d4d0c8; BORDER-BOTTOM: #d4d0c8; BACKGROUND-COLOR: transparent" align=right x:num>0.7</TD><TD style="BORDER-RIGHT: #d4d0c8; BORDER-TOP: #d4d0c8; BORDER-LEFT: #d4d0c8; BORDER-BOTTOM: #d4d0c8; BACKGROUND-COLOR: transparent" align=right x:num x:fmla="=C38-B38">0.22</TD><TD class=xl24 style="BORDER-RIGHT: #d4d0c8; BORDER-TOP: #d4d0c8; BORDER-LEFT: #d4d0c8; BORDER-BOTTOM: #d4d0c8; BACKGROUND-COLOR: transparent" align=right x:num="0.45833333333333331" x:fmla="=D38/B38">45.83%</TD></TR></TBODY></TABLE>

 

[gsgs]

Re: Pandemic threat-level market indicators

thanks.
I was too lazy to do that.

Average: +3.5% since April

 

[Giuseppe]

Re: Pandemic threat-level market indicators

When to hold and when to fold

Ari Sharp - August 25, 2008

CSL chief executive Brian McNamee calls them his A-team: the accountants, lawyers and scientists who sift through the possibilities to find the perfect merger or acquisition.

"We have an A-team," he says. "We love them all dearly; they love M&A. You need people who love the cut and thrust of M&A.

"Due diligence is a hell of an art, and the leadership ? they've got to be pretty good poker players, know when to hold, fold, when to go.

"You know of the successful ones we've done. You probably don't know of the 25 ones we've looked at and walked from. That's the process of M&A, you have to know what the right transaction is, always be willing to walk and you have to be well trained."

This was McNamee's take on corporate activity at a Committee for Economic Development of Australia lunch in Melbourne last month. The speech came just weeks before the A-team superheros gave the nod to the vaccine and blood product company putting $3.5 billion on the table to buy US plasma company Talecris Biotherapeutics.

McNamee has become a legend when it comes to M&A, having bedded down three big acquisitions as part of the company's transformation from a sleepy $23 million government-owned business in the early 1990s to a $21 billion giant that sits 15th on the market capitalisation table.

It is telling that when the Talecris deal was announced, broker and analyst response was positive, with most willing to believe McNamee when he said the deal would add to earnings per share in the first year and that annual synergies would hit $US225 million ($A256 million) for the first three years.

Such enthusiasm is no mean feat given the market's scepticism about blue-sky promises from other chief executives in selling big acquisitions, but seems justified by McNamee's record.

After a string of smaller deals, the first big play came in 2000, when CSL bought Switzerland-based ZLB, then the world's fifth-largest manufacturer of plasma products, for $1 billion.

A year later the company expanded its US business with a $300 million purchase of plasma collection and laboratory facilities from Nabi.

And then its final major play ? until now ? was the purchase of Aventis Behring, the plasma arm of French pharmaceuticals maker Aventis, for nearly $1 billion in 2003.

On all these deals, holding the hand of the A-team was investment bank Merrill Lynch, whose advisory services to CSL are led by London-based Richard Girling, again in the hot seat for the Talecris deal.

Born out of McNamee's experience is an understanding of the importance of value.

"You've got to try and buy well," he said last month. "If you don't buy well, it's such an uphill slog thereafter."

Given these words you can presume he thought hard about Talecris' $3.5 billion price, which he repeatedly described as "fair". It represents 12.7 times Talecris' earnings before interest and tax for the previous year, comparing favourably with trading multiples of similar companies. Wall Street-listed rival Baxter International is trading at 17 times last year's EBIT, Spanish-listed Grifols is trading at 23 times EBIT and CSL itself at 20 times.

Working in McNamee's favour was a seller that was not keen to hold the company in the long run. Private equity firm Cerberus Partners had teamed up with Ampersand Ventures to buy the company from Bayer four years ago, but when the equity market tide went out found it was unable to refloat it. It abandoned a planned US listing and entered into exclusive negotiations with CSL that ultimately bore fruit.

McNamee's musings last month give a hint of what to expect if and when the deal is complete. While patience is his mantra before a purchase, haste takes over when the deal is done.

"We integrate quickly," he says. "If we haven't done it in the first 90 days, then in my view you're not going to get it done, so we absolutely integrate quickly, or ruthlessly."

And McNamee is a man of his word ? the day CSL took over Aventis, 13 top-level managers were shown the door. "That was the signal to the company that we were changing things," he said.

There are no signs that Talecris will need the wholesale changes that McNamee clearly thinks Aventis did, but CSL has already identified ways to improve Talecris' operations.

It plans to boost the yield of plasma products derived from each litre of plasma, and hence increase the revenue generated from each sample collected.

The products derived are used to treat a variety of diseases, many of them rare.

Talecris has a strong market presence with Gamunex, the world's first liquid 10% intravenous immunoglobulin (IVIG), used to treat problems with a patient's immune system, and Prolastin, the world's first treatment for Alpha1-PI deficiency, which can cause respiratory problems.

CSL has also flagged that it will reduce manufacturing bottlenecks and integrate head office staff to avoid duplication.

The purchase will allow CSL to turbocharge its growth in North America, and reorient it towards the world's largest health-care market after earlier leaning more towards Europe.

Despite McNamee's love of a well-timed acquisition, he is been no slouch when it comes to organic growth. The company this month posted 45% annual net profit growth on a constant currency basis, with its core plasma business complemented by a biotherapies business in which sales grew 52%.

That division is now focused on cervical cancer vaccine Gardasil, which performs well despite a recent dip in sales reported by CSL's licensing partner Merck, while vaccines for flu and bird flu recently won approval from regulators.

Getting the Talecris deal over the line will still require US regulators' approval, although the fact the post-acquisition company will still be second in the market for plasma-derived therapeutics behind Baxter will help its cause.

More troublesome could be the market for one product, IVIG, where CSL will now have about half the market on the back of Talecris' Gamunex, with Baxter a distant second.

Several analysts have noted that if the Federal Trade Commission or the Department of Justice start pushing for divestments, the synergy benefits of the deal could start to unravel.

But given McNamee's track record, you can be sure he and his A-team have done their homework.
-
http://business.theage.com.au/busin...20080824-41cv.html?page=fullpage#contentSwap2
------

 

[Binkerbear]

Re: Pandemic threat-level market indicators

I hate to sound obnoxious but the sole purpose of this thread is to get a jump on JIT prepping in case of a pandemic. Right now, the market says there is NO pandemic anywhere on the horizon ... although that could change by the minute !

 

[doe22]

Re: Pandemic threat-level market indicators

Shall I call a tiny signal

BCRX
BioCryst Pharmaceuticals, Inc.
2:17pm ET 2.09 Up 0.34 Up 19.43% 19.00
- - 1.95 1 1.238977?1.24 SVA
SINOVAC BIOTECH LTD
2:18pm ET 1.84 Up 0.14 Up 8.24% 1.95
- - 54.26 1 32.769814?32.77 BAX
Gilead Sciences, Inc.
2:18pm ET 45.61 Down 0.29 Down 0.63% -
- - 227.50 -1 -83.539993?-83.54
ROCHE HLDG G
11:30am ET 139.60 Up 4.70 Up 3.48% 227.50

Novavax, Inc.
2:17pm ET 1.14 Up 0.33 Up 40.73% -
- - - - - BIO

Generex Biotechnology Corporati
2:18PM ET 0.31 Up 0.04 Up 13.44% -
- - - - -